Close Menu

NEW YORK (360Dx) – Nightingale Health today announced a strategic collaboration with PerkinElmer to develop precision medicine solutions.

Nightingale said it has developed a biomarker analysis assay based on nuclear magnetic resonance for disease screening, diagnostics, and treatment-efficacy assessment.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.